CN104435117A - Traditional Chinese medicine composition for treating lymphangioma - Google Patents

Traditional Chinese medicine composition for treating lymphangioma Download PDF

Info

Publication number
CN104435117A
CN104435117A CN201410758055.9A CN201410758055A CN104435117A CN 104435117 A CN104435117 A CN 104435117A CN 201410758055 A CN201410758055 A CN 201410758055A CN 104435117 A CN104435117 A CN 104435117A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
traditional chinese
raw material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410758055.9A
Other languages
Chinese (zh)
Inventor
王正琦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410758055.9A priority Critical patent/CN104435117A/en
Publication of CN104435117A publication Critical patent/CN104435117A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/648—Myriapods, e.g. centipedes or millipedes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Abstract

The invention provides a traditional Chinese medicine composition for treating lymphangioma. The traditional Chinese medicine composition is characterized by being prepared from the following traditional Chinese medicine raw materials in parts by weight: 1-3 parts of musk, 10-30 parts of root of Beijing euphorbia, 10-3 parts of euphorbia kansui, 10-30 parts of semen brassicae, 10-30 parts of stir-baked squama manitis, 5-15 parts of cortex cinnamomi, 5-15 parts of centipede and 10-20 parts of rhizoma bolbostemmae. According to the traditional Chinese medicine composition disclosed by the invention, pure natural Chinese herbal medicines are used; all the raw materials are reasonably combined to take synergic medicinal effects of reinforcing the vital essence and strengthening the primordial qi, so the traditional Chinese medicine composition has the advantages of definite curative effect, small side effects, low treatment cost and the like.

Description

One treats lymphangiomatous Chinese medicine composition
Technical field:
The present invention relates to technical field of Chinese medicine, is exactly specifically that one treats lymphangiomatous Chinese medicine composition.
Background technology:
Because the lymphangioma of lymphatic vessel hypertrophy and expansion is a kind of benign tumor.Tube chamber primarily of endotheliocyte arrangement is formed, and is wherein full of lymph fluid.Because organizational structure difference is divided into again capillary lymphangioma, sponge shape lymphangioma and cystic lymphangioma three types clinically.Child falls ill common, finds that Adult Onset is also common according to clinical observation author, and tumor growth is slow, substantially can not disappear voluntarily.And can only just have the method for operation to treat at present, larger injury can be brought to patient body.
Summary of the invention:
The present invention is exactly to overcome deficiency of the prior art, provides a kind of and lymphangiomatous treatment is had to determined curative effect, side effect are little, the Chinese medicine composition of low in treatment cost.
The invention provides following technical scheme:
One treats lymphangiomatous Chinese medicine composition, it is characterized in that being made up of the raw material of Chinese medicine of following weight proportion: Moschus 1-3 part, Radix Euphorbiae Pekinensis 10-30 part, Radix Kansui 10-30 part, Semen Sinapis Albae 10-30 part, stir-baked SQUAMA MANITIS 10-30 part, Cortex Cinnamomi 5-15 part, Scolopendra 5-15 part, Rhizoma Bolbostematis 10-20 part.
Formula is preferably:
1 part, Moschus, 15 parts, the Radix Euphorbiae Pekinensis, Radix Kansui 20 parts, Semen Sinapis Albae 25 parts, stir-baked SQUAMA MANITIS 15 parts, Cortex Cinnamomi 10 parts, Scolopendra 10 parts, Rhizoma Bolbostematis 15 parts.
Preparation method:
Get above-mentioned each raw material of Chinese medicine by weight ratio, entered screening remove slag-cleaning, drying after for subsequent use; For subsequent use by being ground into 600 order fine powders after Moschus, stir-baked SQUAMA MANITIS, Scolopendra mixing; After using drug weight 4 times of water that other each raw material of Chinese medicine is soaked 30 minutes, decoct 3 times respectively, each decoction 50 minutes, merge after decoction liquor is condensed into the concentrated solution of 1.15 and add 600 order fine powders for subsequent use, dry extract is dried to after abundant stirring, be ground into 400 order fine powders, after adding refined honey, make the pill of 5 grams every.
Method of administration:
Take medicine every day 4 times, every minor tick 6 hours, take medicine 10-20 gram at every turn, and taking continuously 1 week is a course for the treatment of.
The pharmacological effect forming each raw material of Chinese medicine of the present invention is described as follows:
Moschus: acrid in the mouth, warm in nature.GUIXIN, spleen channel.There is refreshment of having one's ideas straightened out, promoting blood circulation to restore menstrual flow, the effects such as reducing swelling and alleviating pain.Be usually used in calentura coma, apoplexy syncope due to accumulation of phlegm, stagnation of QI sudden syncope, attacked by pestiferous factors is gone into a coma, amenorrhea ， WEIJIA, difficult labour stillborn fetus, trusted subordinate's sudden pain, carbuncle scrofula, and laryngopharynx swelling and pain, falls and flutter the pain of injury, and arthralgia pain numbness waits disease.This product also has excited maincenter, strengthen the hypoxia-bearing capability of central nervous system, increased heart rate can be made, blood pressure drops, increase respiratory frequency and the degree of depth, cardiac muscle nutritional blood flow can be increased, there is obvious antiinflammatory action, have and suppress capillary permeability to increase and suppress leukocytoplania effect formidably, energy anticoagulant, preventive and therapeutic action is had to the ischemic heart obstacle caused due to thrombosis, potentiation is had to humoral immunization and cellular immunization, there is destruction in vitro animal cancerous cell and the Cellular respiration of animal tumor tissue had to the effect etc. obviously suppressed.
The Radix Euphorbiae Pekinensis: bitter in the mouth, pungent, cold in nature, poisonous.Return lung, spleen, kidney channel.There is removing water retention by purgation Shen, profit two effect such as just.Be usually used in edema, dropsy, phlegm retention, scrofula, the diseases such as swollen ulcer drug.This product also has all to have inhibitory action to staphylococcus aureus and bacillus pyocyaneus, stimulates intestinal tube, causes enterokinesia to increase, and produces and rushes down inferior effect.
Radix Kansui: bitter in the mouth, cold in nature; Poisonous.Return spleen, lung, kidney, large intestine, small intestine meridian.There is removing water retention by purgation by swollen, the effects such as dispersing swelling and dissipating binds.Be usually used in edema distension, breast abdomen hydrops, the diseases such as phlegm retention is gathered, and QI rising in reverse order is breathed with cough, difficulty in urination and defecation.Zoopery shows: this product can make isolated frog heart contractility strengthen.
Semen Sinapis Albae: acrid in the mouth; Warm in nature.Return lung; Liver; Spleen; Stomach; Pericardium channel.Have and reduce phlegm by drink; The effects such as mass dissipating and swelling eliminating.Be usually used in cough with asthma abundant expectoration; Fullness in the chest and hypochondriac pain; Numb limbs and tense tendons; Arthralgia; Multiple abscess caused by damp-phlegm; The diseases such as carbuncle of yin nature toxic swelling.This product also has antifungic action, promotes the effects such as thyroid hormone secretion.
Stir-baked SQUAMA MANITIS: the scale being exactly Squama Manis(parched).Salty in the mouth, cold nature.Return liver, stomach warp.There is stimulating milk secretion of stimulating the menstrual flow, detumescence and apocenosis, the effects such as expel wind to dredge collateral.Be usually used in Jing Bi WEIJIA, galactostasis, carbuncle sore tumefacting virus, arthralgia, the diseases such as numbness contracture.This product has the effects such as the tolerance reducing blood viscosity effect, antiinflammatory and improve normobaric hypoxia.
Cortex Cinnamomi: acrid in the mouth, sweet, extremely hot in nature.Return kidney, spleen, the heart, Liver Channel.There is benefit fire supporing yang, let the fire back to its origin, dispersing cold for relieving pain, the effects such as promoting blood circulation to restore menstrual flow.Be usually used in sexual impotence, cold womb, chills and pain of the waist and kness, suffer from a deficiency of the kidney and breathe heavily, dizziness due to yang deficiency, conjunctival congestion pharyngalgia, trusted subordinate's cold type of pain, deficiency and coldness is vomited and diarrhoea, colic of cold type, renal mass, amenorrhea, the diseases such as dysmenorrhea.This product has calmness, antipyretic, blood pressure lowering, sterilization and the effect such as blood vessel dilating and increase leukocyte.
Scolopendra: acrid in the mouth, warm in nature; Poisonous.Return Liver Channel.There is endogenous wind stopping spasmolytic, merit poison eliminating stagnation, the effects such as removing obstruction in the collateral to relieve pain.Be usually used in infantile convulsion, tic spasm, middle air port is askew, hemiplegia, tetanus, rheumatoid arthritis stubborn, skin infection, scrofula, the diseases such as venom.This product also has the effects such as antitumor action, relieving convulsion effect and antifungal.
Rhizoma Bolbostematis: bitter in the mouth, cold nature.Return lung, spleen channel.There is eliminating stagnation, detumescence, the effects such as removing toxic substances.Be usually used in acute mastitis, scrofula, mastitis, lymphoid tuberculosis, chronic lymphadenitis, the diseases such as hypertrophic rhinitis.This product also has inhibitory action to cervical cancer, Rhizoma Bolbostematis has facilitation to glandular stomach scale cancer, Tubeimuside I also has the effects such as certain inhibitory action, antivirus action and haemolysis to animal tumor.
The invention has the advantages that:
The present invention selects pure natural Chinese herbal medicine, and each material combination is reasonable, drug effect is collaborative, vital base and primordial QI consolidating has the advantages such as determined curative effect, side effect are little, low in treatment cost for lymphangiomatous treatment.
Detailed description of the invention:
Embodiment 1:
One treats lymphangiomatous Chinese medicine composition, it is characterized in that being made up of the raw material of Chinese medicine of following weight proportion: 1 part, Moschus, 15 parts, the Radix Euphorbiae Pekinensis, Radix Kansui 20 parts, Semen Sinapis Albae 25 parts, stir-baked SQUAMA MANITIS 15 parts, Cortex Cinnamomi 10 parts, Scolopendra 10 parts, Rhizoma Bolbostematis 15 parts.
Embodiment 2:
One treats lymphangiomatous Chinese medicine composition, it is characterized in that being made up of the raw material of Chinese medicine of following weight proportion: 2 parts, Moschus, 15 parts, the Radix Euphorbiae Pekinensis, Radix Kansui 15 parts, Semen Sinapis Albae 20 parts, stir-baked SQUAMA MANITIS 13 parts, Cortex Cinnamomi 13 parts, Scolopendra 8 parts, Rhizoma Bolbostematis 17 parts.
Embodiment 3:
One treats lymphangiomatous Chinese medicine composition, it is characterized in that being made up of the raw material of Chinese medicine of following weight proportion: 3 parts, Moschus, 10 parts, the Radix Euphorbiae Pekinensis, Radix Kansui 10 parts, Semen Sinapis Albae 25 parts, stir-baked SQUAMA MANITIS 25 parts, Cortex Cinnamomi 15 parts, Scolopendra 15 parts, Rhizoma Bolbostematis 20 parts.
Embodiment 1-3 all adopts following preparation and instructions of taking:
Get above-mentioned each raw material of Chinese medicine by weight ratio, entered screening remove slag-cleaning, drying after for subsequent use; For subsequent use by being ground into 600 order fine powders after Moschus, stir-baked SQUAMA MANITIS, Scolopendra mixing; After using drug weight 4 times of water that other each raw material of Chinese medicine is soaked 30 minutes, decoct 3 times respectively, each decoction 50 minutes, merge after decoction liquor is condensed into the concentrated solution of 1.15 and add 600 order fine powders for subsequent use, dry extract is dried to after abundant stirring, be ground into 400 order fine powders, after adding refined honey, make the pill of 5 grams every.
Take medicine every day 4 times, every minor tick 6 hours, take medicine 10-20 gram at every turn, and taking continuously 1 week is a course for the treatment of.

Claims (3)

1. treat a lymphangiomatous Chinese medicine composition, it is characterized in that being made up of the raw material of Chinese medicine of following weight proportion: Moschus 1-3 part, Radix Euphorbiae Pekinensis 10-30 part, Radix Kansui 10-30 part, Semen Sinapis Albae 10-30 part, stir-baked SQUAMA MANITIS 10-30 part, Cortex Cinnamomi 5-15 part, Scolopendra 5-15 part, Rhizoma Bolbostematis 10-20 part.
2. treat lymphangiomatous Chinese medicine composition according to the one described in claim 1, it is characterized in that being made up of the raw material of Chinese medicine of following weight proportion: 1 part, Moschus, 15 parts, the Radix Euphorbiae Pekinensis, Radix Kansui 20 parts, Semen Sinapis Albae 25 parts, stir-baked SQUAMA MANITIS 15 parts, Cortex Cinnamomi 10 parts, Scolopendra 10 parts, Rhizoma Bolbostematis 15 parts.
3. treat the preparation method of lymphangiomatous Chinese medicine composition: it is characterized in that comprising the following steps: get above-mentioned each raw material of Chinese medicine by weight ratio, entered screening remove slag-cleaning, drying after for subsequent use; For subsequent use by being ground into 600 order fine powders after Moschus, stir-baked SQUAMA MANITIS, Scolopendra mixing; After using drug weight 4 times of water that other each raw material of Chinese medicine is soaked 30 minutes, decoct 3 times respectively, each decoction 50 minutes, merge after decoction liquor is condensed into the concentrated solution of 1.15 and add 600 order fine powders for subsequent use, dry extract is dried to after abundant stirring, be ground into 400 order fine powders, after adding refined honey, make the pill of 5 grams every.
CN201410758055.9A 2014-12-12 2014-12-12 Traditional Chinese medicine composition for treating lymphangioma Pending CN104435117A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410758055.9A CN104435117A (en) 2014-12-12 2014-12-12 Traditional Chinese medicine composition for treating lymphangioma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410758055.9A CN104435117A (en) 2014-12-12 2014-12-12 Traditional Chinese medicine composition for treating lymphangioma

Publications (1)

Publication Number Publication Date
CN104435117A true CN104435117A (en) 2015-03-25

Family

ID=52882379

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410758055.9A Pending CN104435117A (en) 2014-12-12 2014-12-12 Traditional Chinese medicine composition for treating lymphangioma

Country Status (1)

Country Link
CN (1) CN104435117A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106492081A (en) * 2016-12-30 2017-03-15 谢娟 A kind of Chinese medicine for treating cavernous lymphangioma

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001052826A2 (en) * 2000-01-20 2001-07-26 Supratek Pharma Inc. Novel podophyllotoxin compositions
CN104095114A (en) * 2014-06-16 2014-10-15 胡安然 Tea for alleviating lymphangioma

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001052826A2 (en) * 2000-01-20 2001-07-26 Supratek Pharma Inc. Novel podophyllotoxin compositions
CN104095114A (en) * 2014-06-16 2014-10-15 胡安然 Tea for alleviating lymphangioma

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
匿名: "求小孩颈部***瘤的偏方", 《百度贴吧》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106492081A (en) * 2016-12-30 2017-03-15 谢娟 A kind of Chinese medicine for treating cavernous lymphangioma

Similar Documents

Publication Publication Date Title
CN102119989B (en) Traditional Chinese medicine capsule for treating lumbar intervertebral disc protrusion, hyperosteogeny, periarthritis humeroscapularis, arthritis and cervical spondylosis
CN103520507A (en) Traditional Chinese medicine composition for treating thyroid cancer
CN100556446C (en) The Chinese medicine of treatment hepatocarcinoma
CN103550695A (en) Medicament for treating breast cancer
CN103977366A (en) Medicine for treating chronic cholecystitis
CN104771729A (en) Traditional Chinese medicine pill assisted to treat lung cancer and preparation method thereof
CN105250878A (en) Traditional Chinese medicine for treating sub-acute infective endocarditis
CN103083573A (en) Traditional Chinese medicine used for treating alcoholic fatty liver
CN104435117A (en) Traditional Chinese medicine composition for treating lymphangioma
CN102688451B (en) Chinese medicinal composition for treating alcoholic fatty liver
CN105998555A (en) Traditional Chinese medicine pill applied to postpartum arthralgia relief and nursing, and preparation method of traditional Chinese medicine pill
CN105250569A (en) Traditional Chinese medicine pill for treating peripheral neuritis and preparation method
CN104338052A (en) Formula of traditional Chinese medicine for treating cerebral thrombosis
CN103948763A (en) Traditional Chinese medicinal composition for treating hepatosis
CN103638369B (en) Traditional Chinese medicinal preparation for treating mastitis
CN103933389B (en) Traditional Chinese medicine composition for treating ovarian cyst
CN107737313A (en) A kind of ointment and manufacture craft for curing carbuncle boils boils
CN102293994A (en) Medicine for treating thyroiditis and preparation method
CN105963619A (en) Traditional Chinese medicine composition for treating uterus coldness infertility
CN104922342A (en) Traditional Chinese medicine for treating rhinitis
CN104800770A (en) Traditional Chinese medicine for treating children respiratory tract infection
CN104740193A (en) Traditional Chinese medicine composition for treating neck-shoulder muscle strain syndrome and preparation method of traditional Chinese medicine composition
CN104523868A (en) Medicine for treating blood stasis stagnating syndrome
CN103989964A (en) Externally-applied medicine for treatment of neck, shoulder, waist and leg pain and sprain
CN103656589A (en) Drug for treating viral myocarditis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150325

RJ01 Rejection of invention patent application after publication